Clinical Trial Update: A Single Center Study to Establish the Imaging Protocol of 99mTc-EC-DG in Evaluating the Presence and Severity of Coronary Artery Disease (CAD) [Phase 2]

View source ↗

Summary

A completed Phase 2 single-center study to establish the imaging protocol for the radiotracer 99mTc-EC-DG in evaluating the presence and severity of Coronary Ar…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• 99mTc-EC-DG (Technetium-99m EC-DG)

Snippet

Sponsor: Cell>Point LLC | Conditions: Coronary Artery Disease | Phase 2 | Status: COMPLETED